CU20100151A7 - Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents

Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Info

Publication number
CU20100151A7
CU20100151A7 CU20100151A CU20100151A CU20100151A7 CU 20100151 A7 CU20100151 A7 CU 20100151A7 CU 20100151 A CU20100151 A CU 20100151A CU 20100151 A CU20100151 A CU 20100151A CU 20100151 A7 CU20100151 A7 CU 20100151A7
Authority
CU
Cuba
Prior art keywords
new
pharmaceutical compositions
compositions containing
preparation procedure
compounds
Prior art date
Application number
CU20100151A
Other languages
English (en)
Inventor
Daniel-Henri Caignard
Monique Mathe
Caroline Louis
Jacques Lebreton
Iuliana Botez
Pierre Lestage
Original Assignee
Univ Nantes
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nantes, Servier Lab filed Critical Univ Nantes
Publication of CU20100151A7 publication Critical patent/CU20100151A7/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de fórmula (I): ESPACIO PARA LA FÓRMULA en la que: R1 representa un átomo de hidrógeno o un grupo metilo, R2 representa un átomo de bromo, un átomo de fluor o un grupo trifluorometilo. Medicamentos.
CU20100151A 2009-07-21 2010-07-20 Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen CU20100151A7 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903573A FR2948368B1 (fr) 2009-07-21 2009-07-21 Nouveaux composes piperidiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CU20100151A7 true CU20100151A7 (es) 2012-03-15

Family

ID=41287719

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100151A CU20100151A7 (es) 2009-07-21 2010-07-20 Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Country Status (29)

Country Link
US (1) US20110021569A1 (es)
EP (1) EP2277863A1 (es)
JP (1) JP2011037845A (es)
KR (1) KR20110009065A (es)
CN (1) CN101962355A (es)
AP (1) AP2010005328A0 (es)
AR (1) AR077418A1 (es)
AU (1) AU2010202875A1 (es)
BR (1) BRPI1004309A2 (es)
CA (1) CA2709551A1 (es)
CL (1) CL2010000742A1 (es)
CO (1) CO6240165A1 (es)
CR (1) CR11567A (es)
CU (1) CU20100151A7 (es)
EA (1) EA201001042A1 (es)
EC (1) ECSP10010358A (es)
FR (1) FR2948368B1 (es)
IL (1) IL206884A0 (es)
MA (1) MA32053B1 (es)
MX (1) MX2010007800A (es)
MY (1) MY150546A (es)
NZ (1) NZ586856A (es)
PE (1) PE20110155A1 (es)
SG (1) SG168483A1 (es)
SV (1) SV2010003626A (es)
TW (1) TW201116512A (es)
UY (1) UY32766A (es)
WO (1) WO2011010015A1 (es)
ZA (1) ZA201005204B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9861941B2 (en) 2011-07-12 2018-01-09 Kraton Polymers U.S. Llc Modified sulfonated block copolymers and the preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0495071A (ja) * 1990-08-10 1992-03-27 Kyorin Pharmaceut Co Ltd カルバミン酸誘導体
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
GB0510140D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B2

Also Published As

Publication number Publication date
MX2010007800A (es) 2011-04-20
SG168483A1 (en) 2011-02-28
EA201001042A1 (ru) 2011-02-28
IL206884A0 (en) 2010-12-30
ZA201005204B (en) 2011-04-28
AP2010005328A0 (en) 2010-08-31
CR11567A (es) 2010-10-08
PE20110155A1 (es) 2011-03-19
CL2010000742A1 (es) 2011-07-08
AR077418A1 (es) 2011-08-24
BRPI1004309A2 (pt) 2012-04-17
FR2948368B1 (fr) 2011-07-22
CA2709551A1 (fr) 2011-01-21
TW201116512A (en) 2011-05-16
MY150546A (en) 2014-01-30
SV2010003626A (es) 2011-01-31
FR2948368A1 (fr) 2011-01-28
JP2011037845A (ja) 2011-02-24
AU2010202875A1 (en) 2011-02-10
MA32053B1 (fr) 2011-02-01
EP2277863A1 (fr) 2011-01-26
CN101962355A (zh) 2011-02-02
ECSP10010358A (es) 2011-02-28
US20110021569A1 (en) 2011-01-27
NZ586856A (en) 2011-11-25
CO6240165A1 (es) 2011-01-20
WO2011010015A1 (fr) 2011-01-27
UY32766A (es) 2011-01-31
KR20110009065A (ko) 2011-01-27

Similar Documents

Publication Publication Date Title
CL2018000730A1 (es) Compuestos heterocíclicos y usos de los mismos
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
CO6511251A2 (es) Compuestos quimicos
CR20150045A (es) Inhibidores de hepatitis c
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
UY33075A (es) Derivados de ciclohexano y usos de los mismos
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
CU20110145A7 (es) Derivados de sulfonamida
UY35485A (es) Compuestos heterocíclicos y usos de los mismos
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
CO6741154A2 (es) Compuestos de triazolopiridina
CR20110592A (es) Aril-piridinas como inhibidoras de sintasa de aldosterona
CO6640270A2 (es) Morfolinopirimidad y su uso en terapia
CR20140275A (es) Triazolopiridinas sustituidas
SV2009003199A (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CU20110113A7 (es) Lactamas como inhibidores beta secretasa
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
UY33348A (es) Compuestos de furopiridina y usos de los mismos
CU20100151A7 (es) Nuevos compuestos piperidínicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY33574A (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
HN2012000485A (es) Nuevos derivados dihidro-oxazolobenzonzodiazepinonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
UY33862A (es) Nuevos compuestos de benzamida, composiciones agroquímicas que los contienen, procesos de preparación y usos?
CR11494A (es) Nuevos derivados de acido 2-mercaptociclopentanocarboxilico, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CO6680616A2 (es) Compuestos de tiofeno 2.3.5- trisustituidos y usos de los mismos
CU20100250A7 (es) Compuestos pirazólicos 436